HIV Scientific Papers
Reduced muscle quality is highly prevalent in aging People With HIV (PWH) and is associated with excess visceral abdominal fat (EVAF)
2025
Zachary Henry, Gary Sinclair, Karam Mounzer, Jordan E. Lake, John R. Koethe, James G. Terry, Sangeeta Nair, John J. Carr, Mohammed Zogheib, Christian Caldji, and Colleen S. McGary
High levels of treatment success seen with combined use of tesamorelin and GLP1-RAs in people with HIV
2025
Daniel Lee, Claudia Martorell, Edwin Calderon, Zachary Henry, Orin Douglas, Christian Caldji, Colleen S. McGary and Kaitlin Anstett
Intramuscular Injection vs Intravenous Infusion of Ibalizumab for HTE PWH: The Results of TMB-302
2024
Kaitlin R. Anstett , R. Brandon Cash , Anthony Mills, Mezgebe Berhe, Edwin DeJesus
Cardiovascular Risk Scores and Insulin Resistance Are Higher With Excess Visceral Abdominal Fat in People With Hiv in the Modern Antiretroviral Era
2024
K. MOUNZER , J.R. KOETHE , J.E. LAKE , M. ZOGHEIB , C.S. McGARY , B. CASH
Efficacy and Safety of 2 Fixed Doses of Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced HIV-Positive Individuals
2024
Edwin DeJesus, MD, William J. Towner, Jr, MD, Joseph C Gathe, MD, R. Brandon Cash, PharmD, and Kaitlin Anstett, PhD